Regulatory Issues

Kadasa Intellectual Property created specialization in handling pharma regulatory issues in Saudi Arabia and other GCC states. Pharma companies operating in the Gulf Region will need to realign their internal and external policies to conform to the constantly evolving guidelines by local health authorities and SFDA. KIP provides a strong support to top management of international pharma companies operating locally in the GCC states. Our services cover legal advises on pharmaceutical registration requirements, patent linkage issues, test data protection issues, import and export of pharmaceutical products, marketing of pharmaceutical products, and code of conduct issues for pharma and health industry.